NBC Securities’s Blueprint Medicines BPMC Stock Holding History

NBC Securities’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-355	Closed	-$45K	–	2787
2025 Q2	$45K	Sell	355 -2,293	-87%	-$238K	﹤0.01%	1367
2025 Q1	$234K	Buy	2,648 +2,646	+132,300%	+$258K	0.02%	723
2024 Q4	$235	Sell	2 -2,723	-100%	-$249K	0.02%	702
2024 Q3	$252K	Buy	2,725 +2,404	+749%	+$239K	0.02%	707
2024 Q2	$34K	Buy	321 +41	+15%	+$4.1K	﹤0.01%	1250
2024 Q1	$26K	Hold	280	–	–	﹤0.01%	1364
2023 Q4	$25K	Sell	280 -51	-15%	-$3.3K	﹤0.01%	1386
2023 Q3	$16K	Buy	+331	New	+$17.7K	﹤0.01%	1537

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NBC Securities's BPMC Position: Q3 2025 in Review

NBC Securities sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 355 shares — an estimated $45K sold.

NBC Securities first reported a position in BPMC in Q3 2023 and held it in 8 quarters. The position peaked at $252K in Q3 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

NBC Securities reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
NBC Securities sold 355 Blueprint Medicines shares in Q3 2025, an estimated $45K.
NBC Securities first reported a position in Blueprint Medicines in Q3 2023 and held it in 8 quarters.
NBC Securities's Blueprint Medicines position peaked at $252K in Q3 2024.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on NBC Securities's 13F filing for Q3 2025, filed 14 Nov 2025.